I’m Sean, the CEO of Olive.
In my previous life, I was an intelligence officer in the Air Force and spent most of my career at the NSA, solving big challenges as a software engineer and technology leader.
Looking for what was next, I was drawn in by the prescription drug abuse problem that consumed my hometown of Gallipolis, Ohio and impacted my family personally. I wanted to do something meaningful, and that’s when I started looking at healthcare.
I began looking at the data and was shocked to realize that nothing was connected. Huge enterprise systems completely unable to communicate with each other or share crucial patient information. It was – and still is – a growing, multi-billion dollar problem.
Instead, healthcare uses humans as routers, forcing workers to toggle between disparate systems – they copy, they paste, they manipulate data – they become robots. And it’s one of the leading reasons that one out of every three dollars spent in the industry today is spent on administrative costs.
With our sights on solving these problems, my team and I iterated over almost a decade looking for the best way to save healthcare. We knew we wanted to change how hospitals fundamentally operated and we saw a dire need to create efficiency at an administrative level.
Suddenly, a lightbulb went on. Instead of building new software to replace the disconnected interfaces, we would build the first healthcare AI workforce to automate the robotic, error-prone workflows themselves, emulating the manual tasks employees were stuck doing – only faster, more accurately and, well, more intelligently.
Today, we call this AI workforce, Olive – the only artificial intelligence and process automation solution designed specifically for healthcare.
Olive works with the leading health systems in the country to uncover and solve the most persistent problems facing healthcare today. She’s proud to partner with more than 40 healthcare organizations made up of more than 600 hospitals in over 41 states across the U.S. – including a growing number of health systems with AlphaSites (onsite centers for AI workforce operations.)
Olive is the only enterprise AI solution built specifically for healthcare. Olive’s growing network of providers and intelligence across healthcare enables our customers to drive rapid value, productivity, and organization-wide impact.
Olive is also the only healthcare-specific AI solution sold as a service (AI-as-a-Service). That means one annual price and an all-in-one approach to optimized workflows and improved revenue. With AI-as-a-Service, health systems get a proven, scalable approach to healthcare AI – one that includes scoping, implementation, support and ongoing optimization.
We think there’s just unlimited potential… [Olive] is so different from a typical IT implementation in that you’re never done… It’s just looking for the next opportunity where we can roll it out and take advantage.
CFO of MemorialCare Health
We went through a formal selection process and found that Olive not only brought the revenue cycle expertise, but more importantly, they brought innovation and talent with an enthusiastic team that blended very well with our culture. This was very important to introduce change and deliver a successful outcome.
Vice President of Patient Financial Services at MedStar Health
With Olive, we were able to reallocate 20 full-time employees to meaningful work, not the hours spent in front of their screens. There were no layoffs because there was so much work to do in the billing office that we just weren’t getting to before.
Sr. Director of Revenue Cycle,
2000+ Bed Health System
Olive’s Executive team has extensive knowledge and experience across both healthcare and technology. But what we share most is a sense of purpose and a willingness to innovate to resolve the most persistent challenges to healthcare. We are dedicated to transforming the future of healthcare with AI.
Chief Executive Officer
Sean is a lifelong technologist who grew up in Ohio and started his career in the U.S. intelligence community, holding leadership positions in the Department of Defense and the National Security Agency. Sean served five combat tours in Iraq and Afghanistan, and was awarded the Defense Meritorious Service Medal and Bronze Star Medal for his service. After government service, Sean started his life as an entrepreneur, and has founded several technology companies dealing with big data, advanced analytics, entity resolution, and most recently, artificial intelligence. Sean has raised over $70M in venture capital, and is now a leading expert in applying Al to healthcare. Sean holds a bachelor’s degree from Miami University, an honorary doctorate of Public Service from the University of Rio Grande, and has received the Ernst & Young Entrepreneur of the Year Award.
President, Provider Market
& Chief Revenue Officer
Lori Jones started her career at Mckesson where she acted as Executive Vice President. Lori brings a decade of experience in sales, customer success, customer operations and leadership roles, with experience managing a $650m provider business and an organization of 300 people. After leaving McKesson, Lori was Executive Vice President and General Manager for Brightree, a provider of clinical software applications for the post acute care industry, where she was part of the executive leadership team that led the company to a successful acquisition by ResMed for $800M in 2016. Prior to joining Olive, Lori was the Chief Revenue Officer for Connance, a healthcare SaaS company which offers RCM and predictive analytics solutions for healthcare that sold to WayStar. And at Olive, Lori has proven to be a key driver behind Olive’s success as she supports Sean’s mission to transform the future of healthcare with AI.
President, Payer Market
Dr. Jeremy Friese, MD MBA, is a physician executive with a demonstrated passion for improving healthcare, first as an academic physician leader at Mayo Clinic then as a successful entrepreneur. Jeremy serves as President, Payer Market at Olive and is on a mission to transform healthcare for the good of patients, providers, and payers. Prior to Olive, Jeremy started or invested in dozens of healthcare companies and co-founded and led Verata Health, a venture-backed AI technology company that pioneered Frictionless Prior Authorization® for payers and providers.
Prior to his transition to entrepreneurship, Jeremy was an internationally recognized physician and executive at Mayo Clinic and Harvard. During his Mayo career, he held executive leadership positions for the $1 billion imaging service line, the Mayo Clinic Strategic Investment Fund, and Global Business Development. Additionally, Jeremy served on several boards including the International Monetary Fund and the American Cancer Society. Dr. Friese earned his MD at Mayo Clinic and his MBA at Harvard Business School.
Jeremy is a proud husband and father of four who loves running, cycling, cooking and traveling.
Chief Financial Officer
Ali is an experienced technology CFO specializing in strategic planning, operational excellence, and transaction execution for global enterprise SaaS companies. Ali joins Olive from CoverWallet, an insurtech leader in small business commercial property and casualty, where he successfully orchestrated the company’s sale Aon plc (NYSE: AON). Ali has delivered billions in cash transaction value for private company shareholders and leading venture capital investors through numerous primary and secondary liquidity events over the past 15 years.
Earlier in his career, Ali spent nearly 10 years at Microsoft, where he launched the company’s Sharepoint business as a product manager, and led strategic planning and growth initiatives for Microsoft’s then $10 billion Office business. He was later responsible for M&A due diligence and post-merger management of acquired companies within Microsoft’s new venture portfolio. Ali holds a bachelor’s degree in Electrical Engineering from Duke University and an MBA in Finance from Wharton.
Chief People Officer
Brian Rutkowski started his career in talent acquisition and business development. Previous to his time at Olive, he led Talent Acquisition at the healthcare startup CoverMyMeds and held numerous leadership positions at Crosschx, successfully championing multiple large-scale initiatives and helping triple the size of the both companies. Throughout his career, Brian has leveraged a results-oriented and innovative approach to build and scale high-growth technology companies and has achieved success in a wide range of environments, from early-stage startups to large organizations. In his current role as Chief Talent Officer, Brian is focused on developing a world class Talent organization – his priorities are building a scalable and adaptive recruiting model, fostering a highly-engaged and collaborative culture, and accelerating the growth of Olive’s business and people.
Chief Marketing Officer
Shoshana is a technology marketing veteran with a 20+ year track record of leading awareness efforts across a “who’s who” of Silicon Valley brands. She joins Olive from Upwork, where she helped to establish the company as a stand-out voice on the future of work — leading awareness efforts through funding rounds, a merger, and the company’s 2018 IPO. Prior to Upwork, Shoshana helped to open the San Francisco office of Penn, Schoen and Berland (PSB), a research consultancy specializing in brand strategy. There, she developed a data-driven approach to marketing which she leverages to create groundbreaking public studies and data-based commentary.
Shoshana also held head of communications roles at Tealeaf (now part of IBM) and Digital Impact (now part of Acxiom). She began her career at the peak of the first dot com boom, and at Bite Communications, represented major brands such as Dolby Laboratories, Veritas Technologies, Siebel CRM Systems and Sun Microsystems (both are now part of Oracle). She holds a double bachelors degree from Stanford University in Communications and Psychology.
Chief Technology Officer
David Landreman started his career by spending several years in higher education healthcare information technology. During this time he got to experience some of the unique challenges in supporting a healthcare IT environment. He left healthcare to lead the evolution of digital presence for a major media company supporting the web and mobile presence for television stations, radio, and newspapers. After meeting Sean Lane, CEO of Olive, David decided to return to the healthcare space in 2013 with the desire to use his skills and experience to further Sean’s vision of transforming healthcare. From growing Olive’s Machine Learning capabilities and building a Robotic Process Automation platform consumable across the healthcare space, to leading the Product Management and R&D Engineering departments at Olive, David is excited to continue making Sean’s Vision actionable across the organization.
Chief Medical Officer
Dr. YiDing Yu, MD, is a practicing physician and serial entrepreneur passionate about transforming the way we imagine and deliver healthcare. Named woman entrepreneur of the year in 2018 by the Cartier Women’s Initiative Awards, YiDing is skilled business operator and passionate public speaker who has launched and scaled innovations across the healthcare ecosystem.
Prior to Olive, YiDing was Chief Medical Officer at Verata Health, a top venture-backed AI company, where she led marketing, customer success, and payer partnerships, and pioneered Frictionless Prior Authorization® for payers and providers. She also founded and served as CEO of Twiage, an award-winning healthcare tech platform for emergency responders. YiDing began her career at Mass General Brigham, where she received the President’s Prize of Value-Based Healthcare Delivery. She’s also served as Chief Innovation Engineer of Atrius Health, a $2B health system in Boston, MA. Recognized throughout her career for her groundbreaking work, YiDing has won top innovation prizes from the American Heart Association, the American Medical Association, and the Cleveland Clinic.
Olive’s Board of Directors reflect an incredible breadth and depth of healthcare, technology, and investment knowledge and experience. From established Fortune 500s to entrepreneurial startups our directors apply their wealth of experience to ensure Olive’s prosperity and continuously drive her cutting edge AI insights toward reimagining the future of healthcare.
Principal, Healthcare, Oak HC/FT
Billy joined Oak HC/FT as a Principal in 2018. Prior to joining Oak HC/FT, Billy was with Francisco Partners, a technology-focused private equity firm, where he helped lead investments and served on the boards of several companies across healthcare, fintech, and application software. Billy was previously with TPG Growth, the early stage investment platform of TPG Capital, where he focused on investments in healthcare, software, financial services, and consumer products. Billy began his career in the Media & Communications investment banking group at UBS and alsoworked with the lending platform Funding Circle during the early stages of its US operations. Billy graduated cum laude from Yale University with a BA in History and earned an MBA from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar.
Partner, Drive Capital
A native of Cincinnati, Chris built his career investing in emerging technology and healthcare companies. Prior to co-founding Drive Capital, Chris was at Sequoia Capital for six years where he led and managed the firm’s growth investing practice. His investments include LitePoint (Teradyne), Klarna, Weebly, Electronic Arts (EA – NASDAQ), GSI Commerce (EBay) and eMeter (Siemens). Before Sequoia, Chris was an investor with Technology Crossover Ventures. Chris briefly dropped out of Yale to compete on the professional squash circuit, where he quickly learned he was better suited to work with entrepreneurs.
Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine of USC
Dr. Agus is a professor of medicine and engineering at the University of Southern California (USC) Keck School of Medicine and Viterbi School of Engineering and the CEO and founding director of USC’s Lawrence J. Ellison Institute for Transformative Medicine. He is one of the world’s leading physicians specializing in treating patients with advanced forms of cancer, is the co-founder of several personalized medicine companies and has served in leadership roles at the World Economic Forum. Over the years he has treated a number of high-profile patients, including Steve Jobs and Lance Armstrong. Dr. Agus holds degrees from Princeton University and the University of Pennsylvania School of Medicine.
Former Chairman and CEO, Cardinal Health, Inc.
George held the role of chairman and CEO for the majority of his tenure, from August 2009 to the end of 2017, serving as executive chairman until November 2018. Under his leadership, Cardinal Health grew to rank 15th on the Fortune 500 with annual revenue of more than $130 billion and 50,000 employees in 60 countries. During his tenure, the company received a number of accolades, including Fortune’s World’s Most Admired Companies, Forbes America’s Best Employers, The Wall Street Journal’s Drucker Institute’s Top Companies for Corporate Social Responsibility, National Association for Female Executives’ Top Companies for Executive Women, Chief Executive Magazine’s Top Companies for Talent Development, and a host of awards for its public health and philanthropic activities. Barrett earned his Bachelor of Arts degree from Brown University and a Master of Business Administration from New York University. He holds an Honorary Doctor of Humane Letters degree from Long Island University’s Arnold & Marie Schwartz College of Pharmacy and Health Sciences and an Honorary Doctorate in Fine Arts from the Columbus College of Art & Design.
Investment Director, Ascension Ventures
John Kuelper joined Ascension Ventures in 2014 as a Kauffman Fellow. John is Founder and President of Qualia Holdings LLC, a platform for systems biology and therapeutic ventures. He has advised or worked for several investment firms (Adams Street Partners, Sterling Partners, Abundant Venture Partners), medical technology companies (Stereotaxis, Orpheden Therapeutics), and nonprofits (The Kresge Foundation, the Blue Cross and Blue Shield Association). John began his career as a medical researcher studying computational neuroscience and medical robotics and has over fifteen years of experience as a commercial software developer. John earned JD and MBA degrees from the Northwestern University Pritzker School of Law and Kellogg School of Management where he graduated with honors and was elected Beta Gamma Sigma (top 10% of class). He earned a BA in cognitive neuroscience from Washington University in St. Louis, graduating magna cum laude. In 2014 he was elected to the Kauffman Fellows Society. In his spare time, John enjoys hiking and camping with his two dogs and listening to live music.
Former CEO, Mission Health
Ronald A. Paulus, MD, is President and CEO of RAPMD Strategic Advisors. He is also an Executive in Residence at General Catalyst and past President and CEO of Mission Health, a $1.9 billion integrated health system serving all of western North Carolina. Before joining Mission Health System, Dr. Paulus was EVP, Clinical Operations and CIO at Geisinger Health System, where he managed Geisinger’s hospitals and its more than 800 physician group practice. Prior to joining Geisinger, Dr. Paulus was co-founder, President and later CEO of CareScience, Inc. (previously NASDAQ: CARE), now part of Premier healthcare informatics with the software in use in nearly 1,000 hospitals and health systems nationwide. Dr. Paulus received his MD degree from The School of Medicine, University of Pennsylvania, and his MBA, concentration in healthcare management, and BS in Economics from The Wharton School, University of Pennsylvania. He has published and speaks regularly on the topics of healthcare quality and efficiency, using analytics to transform care delivery, innovation, physician leadership, and new models of care. In 2014, Dr. Paulus was voted one of Modern Healthcare’s Top 50 Most Influential Physician Executives and Leaders, and was among the Top 20 on that list.
Strategic partnerships are critical to Olive’s success. There are many companies out there working alongside Olive to solve the most costly challenges facing healthcare today. Whether you’re a technology company or a consultant wanting to partner with Olive, we would love to begin the conversation.
We’re booked for 2020. Are you? From HFMA regionals to Becker’s and more, join Olive CEO Sean Lane as he speaks to how AI and automation can increase efficiency and reduce costs for your healthcare organization.
Impactful. Pioneering. Willing to do whatever it takes. Olive is for people who buck the status quo and are willing to take up the challenge of fixing the healthcare industry – ready to throw down the gauntlet?